It then maps shared CRC–T2DM nodes (insulin/IGF signaling, AMPK–mTOR crosstalk, inflammation, microbiome-driven biotransformation) to justify urolithins as dual-purpose modulators. This evidence concerns the gene MTOR and type 2 diabetes mellitus.